UNSPSC 85522901: Revision of nonautologous tissue substitute in upper vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in upper vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05WY3KZ

UNSPSC 85522901 Revision of nonautologous tissue substitute in upper vein, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its nominal clinical scope. The six most recent state and local opportunities tagged to this code span occupational medical surveillance, disability benefit medical evaluations, surgical benefit carve-outs, pharmacy benefit management, temporary health professional staffing, emergency medical services for detained youth, and related administrative health services — none of which involve tissue substitute revision procedures or vascular interventions. The mismatch suggests either systematic tagging drift in the source jurisdictions' procurement systems or that the code's application to these opportunities does not reflect the clinical procedure the code nominally describes.

The issuing bodies include a state department (Washington State Department of Transportation), county governments (Harris County, Collier County, Santa Clara County), and a city retirement office (City of Phoenix), indicating broad geographic and jurisdictional reach. Recent opportunities range from medical surveillance contracts (WSDOT, $750,000 over five years for Phoenix), pharmacy management (Collier County, approximately $8.7 million historically), and temporary staffing pools (Santa Clara County Health System). The code shows activity across Arizona, California, Florida, Texas, and Washington, but the disconnect between the Commodity code's stated clinical focus and the actual procurements raises questions about whether this code is the appropriate taxonomy label for these health services acquisitions.